Patient evaluation and selection for transcatheter aortic valve replacement: The heart team approach

Progress in Cardiovascular Diseases

Volumn 56, Issue 6, 2014, Pages 572-582

  Sintek, Marc ^a   Zajarias, Alan ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Heart team; Patient eligibility; Patient selection; Transcatheter aortic valve replacement

Indexed keywords

AORTA STENOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; FRAILTY; HEALTH CARE PLANNING; HEART CATHETERIZATION; HISTORY OF MEDICINE; HUMAN; MITRAL VALVE DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SELECTION; RISK ASSESSMENT; SYSTOLIC DYSFUNCTION; TRANSCATHETER AORTIC VALVE IMPLANTATION; WEAKNESS;

HEART TEAM; PATIENT ELIGIBILITY; PATIENT SELECTION; TRANSCATHETER AORTIC VALVE REPLACEMENT;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; DECISION SUPPORT TECHNIQUES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MULTIMODAL IMAGING; PATIENT CARE TEAM; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84900029278     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.02.003     Document Type: Article

References (97)

1. Leon M.B., Smith C.R., Mack M., Miller D.C., Moses J.W., Svensson L.G., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363:1597-1607.
2. Smith C.R., Leon M.B., Mack M.J., Miller D.C., Moses J.W., Svensson L.G., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011, 364:2187-2198.
3. Holmes D.R., Mack M.J., Kaul S., Agnihotri A., Alexander K.P., Bailey S.R., et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012, 59:1200-1254.
4. Tang G.H.L., Lansman S.L., Cohen M., Spielvogel D., Cuomo L., Ahmad H., et al. Transcatheter aortic valve replacement: current developments, ongoing issues, future outlook. Cardiol Rev 2013, 21:55-76.
5. Serruys P.W., Morice M.-C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360:961-972.
6. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1996, 335:217-225.
7. Ong A.T.L., Serruys P.W., Mohr F.W., Morice M.-C., Kappetein A.P., Holmes D.R., et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006, 151:1194-1204.
8. Jacques L., Jensen T., Schafer J., Fulton S., Schott L. Decision memo for transcatheter aortic valve replacement (TAVR) (CAG-00430N) 2012, [at
9. Holmes D.R., Mohr F., Hamm C.W., Mack M.J. Venn diagrams in cardiovascular disease: the Heart Team concept. Eur J Cardiothorac Surg 2013, 43:255-257.
10. Holmes D.R., Rich J.B., Zoghbi W.A., Mack M.J. The heart team of cardiovascular care. J Am Coll Cardiol 2013, 61:903-907.
11. O'Brien S.M., Shahian D.M., Filardo G., Ferraris V.A., Haan C.K., Rich J.B., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009, 88:S23-S42.
12. Mack M.J. Risk scores for predicting outcomes in valvular heart disease: how useful?. Curr Cardiol Rep 2011, 13:107-112.
13. Wendt D., Osswald B.R., Kayser K., Thielmann M., Tossios P., Massoudy P., et al. Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg 2009, 88:468-474. [discussion 474-475].
14. Toumpoulis I.K., Anagnostopoulos C.E., Toumpoulis S.K., DeRose J.J., Swistel D.G. EuroSCORE predicts long-term mortality after heart valve surgery. Ann Thorac Surg 2005, 79:1902-1908.
15. Durand E., Borz B., Godin M., Tron C., Litzler P.-Y., Bessou J.-P., et al. Performance analysis of EuroSCORE II compared to the original Logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2013, 111:891-897.
16. Piazza N., van Gameren M., Jüni P., Wenaweser P., Carrel T., Onuma Y., et al. A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study. EuroIntervention 2009, 5:580-588.
17. Ben-Dor I., Gaglia M.A., Barbash I.M., Maluenda G., Hauville C., M.A., et al. Comparison between Society of Thoracic Surgeons score and logistic EuroSCORE for predicting mortality in patients referred for transcatheter aortic valve implantation. Cardiovasc Revasc Med 2011, 12:345-349.
18. Goetzenich A., Deppe I., Schnöring H., Gafencu G.L., Gafencu D.-A., Yildirim H., et al. EuroScore 2 for identification of patients for transapical aortic valve replacement-a single center retrospective in 206 patients. J Cardiothorac Surg 2012, 7:89.
19. Nashef S.A.M., Roques F., Sharples I.D., Nilsson J., Smith C., Goldstone A.R., et al. EuroSCORE II. Eur J Cardiothorac Surg 2012, 41:734-744. [discussion 744-745].
20. Ranucci M., Castelvecchio S., Menicanti L., Frigiola A., Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation 2009, 119:3053-3061.
21. Stortecky S., Schoenenberger A.W., Moser A., Kalesan B., Jüni P., Carrel T., et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012, 5:489-496.
22. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
23. Fried L.P., Ferrucci L., Darer J., Williamson J.D., Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004, 59:255-263.
24. Afilalo J., Karunananthan S., Eisenberg M.J., Alexander K.P., Bergman H. Role of frailty in patients with cardiovascular disease. Am J Cardiol 2009, 103:1616-1621.
25. Newman A.B., Gottdiener J.S., Mcburnie M.A., Hirsch C.H., Kop W.J., Tracy R., et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001, 56:M158-M166.
26. Purser J.L., Kuchibhatla M.N., Fillenbaum G.G., Harding T., Peterson E.D., Alexander K.P. Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc 2006, 54:1674-1681.
27. Fugate Woods N., LaCroix A.Z., Gray S.L., Aragaki A., Cochrane B.B., Brunner R.L., et al. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 2005, 53:1321-1330.
28. Cacciatore F., Abete P., Mazzella F., Viati L., Della Morte D., D'Ambrosio D., et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest 2005, 35:723-730.
29. Green P., Woglom A.E., Genereux P., Daneault B., Paradis J.-M., Schnell S., et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv 2012, 5:974-981.
30. Singh M., Alexander K., Roger V.L., Rihal C.S., Whitson H.E., Lerman A., et al. Frailty and its potential relevance to cardiovascular care. Mayo Clin Proc 2008, 83:1146-1153.
31. Krumholz H.M., Chen J., Chen Y.T., Wang Y., Radford M.J. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol 2001, 38:453-459.
32. Mack M. Frailty and aortic valve disease. J Thorac Cardiovasc Surg 2013, 145:S7-S10.
33. Stone M.L., Kern J.A., Sade R.M. Transcatheter aortic valve replacement: clinical aspects and ethical considerations. Ann Thorac Surg 2012, 94:1791-1795.
34. Sündermann S., Dademasch A., Praetorius J., Kempfert J., Dewey T., Falk V., et al. Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur J Cardiothorac Surg 2011, 39:33-37.
35. Green P., Woglom A.E., Genereux P., Maurer M.S., Kirtane A.J., Hawkey M., et al. Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis. Clin Cardiol 2012, 35:307-314.
36. Studenski S. Gait speed and survival in older adults. JAMA 2011, 305:50.
37. Green P., Cohen D.J., Généreux P., McAndrew T., Arnold S.V., Alu M., et al. Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER Trial). Am J Cardiol 2013, 10.1016/j.amjcard.2013.04.046.
38. Dewey T.M. Frailty scores and the writing on the wall. JACC Cardiovasc Interv 2012, 5:497-498.
39. Rosner M.H., Okusa M.D. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006, 1:19-32.
40. Bagur R., Webb J.G., Nietlispach F., Dumont E., De Larochellière R., Doyle D., et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010, 31:865-874.
41. Aregger F., Wenaweser P., Hellige G.J., Kadner A., Carrel T., Windecker S., et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 2009, 24:2175-2179.
42. Kong W.Y., Yong G., Irish A. Incidence, risk factors and prognosis of acute kidney injury after transcatheter aortic valve implantation. Nephrology (Carlton) 2012, 17(445-451).
43. Thomas M., Schymik G., Walther T., Himbert D., Lefèvre T., Treede H., et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011, 124:425-433.
44. Sinning J.-M., Ghanem A., Steinhäuser H., Adenauer V., Hammerstingl C., Nickenig G., et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010, 3:1141-1149.
45. Yamamoto M., Hayashida K., Mouillet G., Hovasse T., Chevalier B., Oguri A., et al. Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. J Am Coll Cardiol 2013, 10.1016/j.jacc.2013.04.057.
46. Aranki S.F., Rizzo R.J., Couper G.S., Adams D.H., Collins J.J., Gildea J.S., et al. Aortic valve replacement in the elderly. Effect of gender and coronary artery disease on operative mortality. Circulation 1993, 88:II17-II23.
47. Lund O., Nielsen T.T., Pilegaard H.K., Magnussen K., Knudsen M.A. The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 1990, 100:327-337.
48. Dewey T.M., Brown D.L., Herbert M.A., Culica D., Smith C.R., Leon M.B., et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 2010, 89:758-767. [discussion 767].
49. Goel S.S., Ige M., Tuzcu E.M., Ellis S.G., Stewart W.J., Svensson L.G., et al. Severe aortic stenosis and coronary artery disease-implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll Cardiol 2013, 62:1-10.
50. Masson J.-B., Lee M., Boone R.H., Al Ali A., Al Bugami S., Hamburger J., et al. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010, 76:165-173.
51. Conradi L., Seiffert M., Franzen O., Baldus S., Schirmer J., Meinertz T., et al. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol 2011, 100:311-316.
52. Pasic M., Dreysse S., Unbehaun A., Buz S., Drews T., Klein C., et al. Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg 2012, 14:463-468.
53. Piazza N., Serruys P.W., de Jaegere P. Feasibility of complex coronary intervention in combination with percutaneous aortic valve implantation in patients with aortic stenosis using percutaneous left ventricular assist device (TandemHeart). Catheter Cardiovasc Interv 2009, 73:161-166.
54. Webb J.G. Strategies in the management of coronary artery disease and transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2009, 73:68.
55. Gunter R.L., Kilgo P., Guyton R.A., Chen E.P., Puskas J.D., Cooper W.A., et al. Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement. Ann Thorac Surg 2013, 96:1322-1328.
56. Moat N.E., Ludman P., de Belder M.A., Bridgewater B., Cunningham A.D., Young C.P., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011, 58:2130-2138.
57. Rodés-Cabau J., Webb J.G., Cheung A., Ye J., Dumont E., Osten M., et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 2012, 60:1864-1875.
58. Thourani V.H., Chowdhury R., Gunter R.L., Kilgo P.D., Chen E.P., Puskas J.D., et al. The impact of specific preoperative organ dysfunction in patients undergoing aortic valve replacement. Ann Thorac Surg 2013, 95:838-845.
59. Dvir D., Waksman R., Barbash I.M., Kodali S.K., Svensson L.G., Tuzcu E.M., et al. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER Trial (Placement of AoRTic TraNscathetER Valve). J Am Coll Cardiol 2014, 63:269-279.
60. Arnold S.V., Spertus J.A., Lei Y., Green P., Kirtane A.J., Kapadia S., et al. How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial. Circ Cardiovasc Qual Outcomes 2013, 6:591-597.
61. Hutter A., Bleiziffer S., Richter V., Opitz A., Hettich I., Mazzitelli D., et al. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation. Ann Thorac Surg 2013, 95:77-84.
62. Barreiro C.J., Patel N.D., Fitton T.P., Williams J.A., Bonde P.N., Chan V., et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation 2005, 112:I443-I447.
63. Wan C.K.N., Suri R.M., Li Z., Orszulak T.A., Daly R.C., Schaff H.V., et al. Management of moderate functional mitral regurgitation at the time of aortic valve replacement: is concomitant mitral valve repair necessary?. J Thorac Cardiovasc Surg 2009, 137:635-640. [e1].
64. Hahn R.T., Pibarot P., Stewart W.J., Weissman N.J., Gopalakrishnan D., Keane M.G., et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in Cohort A of the PARTNER Trial (Placement of Aortic Transcatheter Valves). J Am Coll Cardiol 2013, 61:2514-2521.
65. Melby S.J., Moon M.R., Lindman B.R., Bailey M.S., Hill L.L., Damiano R.J. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 2011, 141:1424-1430.
66. Roselli E.E., Abdel Azim A., Houghtaling P.L., Jaber W.A., Blackstone E.H. Pulmonary hypertension is associated with worse early and late outcomes after aortic valve replacement: implications for transcatheter aortic valve replacement. J. Thorac. Cardiovasc. Surg 2012, 144:1067-1074. [e2].
67. Halkos M.E., Chen E.P., Sarin E.L., Kilgo P., Thourani V.H., Lattouf O.M., et al. Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction. Ann Thorac Surg 2009, 88:746-751.
68. Morris J.J., Schaff H.V., Mullany C.J., Rastogi A., McGregor C.G., Daly R.C., et al. Determinants of survival and recovery of left ventricular function after aortic valve replacement. Ann Thorac Surg 1993, 56:22-29. [discussion 29-30].
69. Ewe S.H., Ajmone Marsan N., Pepi M., Delgado V., Tamborini G., Muratori M., et al. Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J 2010, 160:1113-1120.
70. Clavel M.A., Webb J.G., Rodés-Cabau J., Masson J.B., Dumont E., De R., et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 2010, 122:1928-1936.
71. van der Boon R.M., Nuis R.-J., Van Mieghem N.M., Benitez L.M., van Geuns R.-J., Galema T.W., et al. Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function. Catheter Cardiovasc Interv 2012, 79:702-710.
72. Zhao Y., Lindqvist P., Nilsson J., Holmgren A., Näslund U., Henein M.Y. Trans-catheter aortic valve implantation-early recovery of left and preservation of right ventricular function. Interact Cardiovasc Thorac Surg 2011, 12:35-39.
73. Forsberg L.M., Tamás E., Vánky F., Nielsen N.E., Engvall J., Nylander E. Left and right ventricular function in aortic stenosis patients 8weeks post-transcatheter aortic valve implantation or surgical aortic valve replacement. Eur J Echocardiogr 2011, 12:603-611.
74. Carabello B.A. Low-gradient, low-ejection fraction aortic stenosis. JACC 2012, 5:560-562.
75. Gotzmann M., Lindstaedt M., Bojara W., Ewers A., Mügge A. Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis. Catheter Cardiovasc Interv 2012, 79:693-701.
76. Lauten A., Zahn R., Horack M., Sievert H., Linke A., Ferrari M., et al. Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. JACC Cardiovasc Interv 2012, 5:552-559.
77. Gotzmann M., Pljakic A., Bojara W., Lindstaedt M., Ewers A., Germing A., et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am Heart J 2011, 162:238-245. [e1].
78. Eltchaninoff H., Kerkeni M., Zajarias A., Tron C., Godin M., Sanchez C., et al. Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesis. EuroIntervention 2009, 5:438-442.
79. Binder R.K., Rodés-Cabau J., Wood D.A., Mok M., Leipsic J., De Larochellière R., et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 2013, 6:293-300.
80. Joshi S.B., Mendoza D.D., Steinberg D.H., Goldstein M.A., Lopez C.F., Raizon A., et al. Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography. JACC Cardiovasc Imaging 2009, 2:1404-1411.
81. Babaliaros V.C., Liff D., Chen E.P., Rogers J.H., Brown R.A., Thourani V.H., et al. Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size?. JACC Cardiovasc Interv 2008, 1:580-586.
82. Jayasuriya C., Moss R.R., Munt B. Transcatheter aortic valve implantation in aortic stenosis: the role of echocardiography. J Am Soc Echocardiogr 2011, 24:15-27.
83. Altiok E., Koos R., Schröder J., Brehmer K., Hamada S., Becker M., et al. Comparison of two-dimensional and three-dimensional imaging techniques for measurement of aortic annulus diameters before transcatheter aortic valve implantation. Heart 2011, 97:1578-1584.
84. Jilaihawi H., Doctor N., Kashif M., Chakravarty T., Rafique A., Makar M., et al. Aortic annular sizing for transcatheter aortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. J Am Coll Cardiol 2013, 61:908-916.
85. Ng A.C.T., Delgado V., van der Kley F., Shanks M., van de Veire N.R.L., Bertini M., et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging 2010, 3:94-102.
86. Piazza N., de Jaegere P., Schultz C., Becker A.E., Serruys P.W., Anderson R.H. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 2008, 1:74-81.
87. Messika-Zeitoun D., Serfaty J.-M., Brochet E., Ducrocq G., Lepage L., Detaint D., et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010, 55:186-194.
88. Détaint D., Lepage L., Himbert D., Brochet E., Messika-Zeitoun D., Iung B., et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2009, 2:821-827.
89. Gripari P., Ewe S.H., Fusini L., Muratori M., Ng A.C.T., Cefalù C., et al. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation. Heart 2012, 98:1229-1236.
90. Bloomfield G.S., Gillam L.D., Hahn R.T., Kapadia S., Leipsic J., Lerakis S., et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2012, 5:441-455.
91. Tops L.F., Wood D.A., Delgado V., Schuijf J.D., Mayo J.R., Pasupati S., et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2008, 1:321-330.
92. Toggweiler S., Gurvitch R., Leipsic J., Wood D.A., Willson A.B., Binder R.K., et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol 2012, 59:113-118.
93. Hayashida K., Lefèvre T., Chevalier B., Hovasse T., Romano M., Garot P., et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011, 4:851-858.
94. Wood D.A., Tops L.F., Mayo J.R., Pasupati S., Schalij M.J., Humphries K., et al. Role of multislice computed tomography in transcatheter aortic valve replacement. Am J Cardiol 2009, 103:1295-1301.
95. Latsios G., Gerckens U., Grube E. Transaortic transcatheter aortic valve implantation: a novel approach for the truly 'no-access option' patients. Catheter Cardiovasc Interv 2010, 75:1129-1136.
96. Lardizabal J.A., O'Neill B.P., Desai H.V., Macon C.J., Rodriguez A.P., C.A., et al. The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States. J Am Coll Cardiol 2013, 61:2341-2345.
97. Covello R.D., Maj G., Landoni G., Maisano F., Michev I., Guarracino F., et al. Anesthetic management of percutaneous aortic valve implantation: focus on challenges encountered and proposed solutions. J Cardiothorac Vasc Anesth 2009, 23:280-285.